PerkinElmer Revenue and Competitors

Boston, MA USA

Location

$6.9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PerkinElmer's estimated annual revenue is currently $5.1B per year.(i)
  • PerkinElmer's estimated revenue per employee is $664,740
  • PerkinElmer's total funding is $6.9M.
  • PerkinElmer's current valuation is $22.5B. (January 2022)

Employee Data

  • PerkinElmer has 7612 Employees.(i)
  • PerkinElmer grew their employee count by -20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$668.1M32223%$20MN/A
#2
$5.3M46N/AN/AN/A
#3
$5.1M46-13%$950KN/A
#4
$1.7M23-4%$30MN/A
#5
$0.7M9N/AN/AN/A
#6
$0.7M9N/AN/AN/A
#7
$0.6M8N/AN/AN/A
#8
$2.5M25N/AN/AN/A
#9
$71M300-3%N/AN/A
#10
$14.2M98N/AN/AN/A
#11
$53.7M3027%$8MN/A
#12
$3.8M33N/AN/AN/A
#13
$4.2M21N/AN/AN/A
#14
$7.6M5832%N/AN/A
#15
$25.7M161N/AN/AN/A
#16
$1167M5806N/AN/AN/A
#17
$16.5M82N/AN/AN/A
#18
$12.7M91-9%$17.2MN/A
#19
N/A39N/AN/AN/A
#20
$1.7M244%$5.1MN/A
Add Company

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately 3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

keywords:saas

$6.9M

Total Funding

7612

Number of Employees

$5.1B

Revenue (est)

-20%

Employee Growth %

$22.5B

Valuation

N/A

Accelerator

PerkinElmer's People

NameTitleEmail/Phone
1
SVP- Administration, General Counsel and SecretaryReveal Email/Phone
2
EHS DirectorReveal Email/Phone
3
Principal BD and Strategy Leader, Discovery and Analytical SolutionsReveal Email/Phone
4
Contracts Manager, Managed MarketsReveal Email/Phone
5
Sr. R&D Quality EngineerReveal Email/Phone
6
Sr. IT Vendor SpecialistReveal Email/Phone
7
Logistics ManagerReveal Email/Phone
8
VP, Marketing (SDx)Reveal Email/Phone
9
HCS Sales SpecialistReveal Email/Phone
10
LAS Six Sigma SWAT Team LeaderReveal Email/Phone

PerkinElmer News

2022-04-20 - PerkinElmer, Inc. (NYSE:PKI) Given Consensus Rating of “Buy ...

PerkinElmer, Inc. (NYSE:PKI) Given Consensus Rating of “Buy” by Brokerages. Posted by admin on Apr 25th, 2022. Share on Twitter Share on Facebook Share on...

2022-04-17 - California will close its central COVID-19 lab, cancel $1.7 ...

The letter thanked PerkinElmer for its partnership and noted the increased availability of antigen testing and expanded commercial testing...

2022-04-06 - PerkinElmer to lay off 75 amid termination of California COVID ...

The cuts are linked to a contract PerkinElmer signed with California's Department of Public Health (CDPH) in August 2020 to provide COVID-19 lab testing and...

2021-07-26 - PerkinElmer Agrees to Acquire BioLegend

PerkinElmer, Inc. (NYSE: PKI) entered into an agreement to acquire San Diego-based BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion. The acquisition deal will be a combination of cash and stock, subject to certain adjustments accordin ...

2021-07-22 - PerkinElmer : COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

PDF Version Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer WHAT:PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the U.S. Food and Drug Administration (FDA) has authorized ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4845.3M10649N/AN/A
#2
$2455M118406%$156.9M
#3
$6388.4M26842N/AN/A
#4
$10959.4M283851%$66.5M
#5
$63760M497276%N/A